|
Story |
Headlines On Deadline ... |
webadmin |
|
Story |
Single and family enrollment in high-premium plans |
webadmin |
|
Story |
Home Infusion Therapy Covered Well by Insurers |
webadmin |
|
Story |
At-Home Monitors Help BP Control |
webadmin |
|
Story |
Hospital Costs Grow 25 Percent |
webadmin |
|
Story |
Individual Premiums Rise 20 Percent |
webadmin |
|
Story |
For heart drugs, greater generic penetration |
webadmin |
|
Story |
Comparison of Amlodipine/Valsartan Fixed-Dose Combination Therapy and Conventional Therapy |
webadmin |
|
Story |
Medical Home Pilot Offers Docs Leeway |
webadmin |
|
Story |
Specialists Putting Mark On Strained Primary Care |
webadmin |
|
Story |
Employers Want More Cooperation From Plans: A Conversation with Larry S. Boress |
webadmin |
|
Story |
Financed by the Feds, States Get Tougher on Rates |
webadmin |
|
Story |
Vaccination: Is 1 oz. of Prevention Still Worth 1 lb. of Cure? |
webadmin |
|
Story |
Medicare’s New Head — And What He’s Said |
webadmin |
|
Story |
Avoiding Infusion Therapy Prime Benefit of New MS Drug |
webadmin |
|
Story |
Health Plans Prepare to Meet Challenges of Climate Change |
webadmin |
|
Story |
Despite downturn, pharmacy jobs abound |
webadmin |
|
Story |
Patient-Centered Medical Home Deserves Rigorous Evaluation |
webadmin |
|
Story |
Who pays more for second- and third-tier drugs? |
webadmin |
|
Story |
Lessons Learned in Building The Patient-Centered Medical Home |
webadmin |
|
Story |
The Forces That Feed Medical Travel |
webadmin |
|
Story |
More Eye Exams In Stand-Alone Plans |
webadmin |
|
Story |
Headlines On Deadline … |
webadmin |
|
Story |
Membership rolls in free fall |
webadmin |
|
Story |
NCQA Revises 6 HEDIS Measures |
webadmin |
